Methods of treatment with Syk inhibitors

    公开(公告)号:AU2005235289A1

    公开(公告)日:2005-11-03

    申请号:AU2005235289

    申请日:2005-04-18

    Abstract: The present invention provides novel compositions and methods for inhibiting restenosis, thrombosis, and/or inflammation in a patient undergoing a vascular intervention. More particularly, the present invention provides intravascular devices coated with one or more spleen tyrosine kinase (Syk) inhibitors. Methods for inhibiting restenosis, thrombosis, and/or inflammation in a patient by treatment with such intravascular devices are also provided. In addition, the present invention provides methods for treating sickle cell disease using Syk inhibitors.

    Methods of treatment with Syk inhibitors

    公开(公告)号:AU2005235289B2

    公开(公告)日:2010-10-28

    申请号:AU2005235289

    申请日:2005-04-18

    Abstract: The present invention provides novel compositions and methods for inhibiting restenosis, thrombosis, and/or inflammation in a patient undergoing a vascular intervention. More particularly, the present invention provides intravascular devices coated with one or more spleen tyrosine kinase (Syk) inhibitors. Methods for inhibiting restenosis, thrombosis, and/or inflammation in a patient by treatment with such intravascular devices are also provided. In addition, the present invention provides methods for treating sickle cell disease using Syk inhibitors.

    METHODS OF TREATMENT WITH SYK INHIBITORS

    公开(公告)号:CA2562734A1

    公开(公告)日:2005-11-03

    申请号:CA2562734

    申请日:2005-04-18

    Abstract: The present invention provides novel compositions and methods for inhibiting restenosis, thrombosis, and/or inflammation in a patient undergoing a vascul ar intervention. More particularly, the present invention provides intravascula r devices coated with one or more spleen tyrosine kinase (Syk) inhibitors. Methods for inhibiting restenosis, thrombosis, and/or inflammation in a patient by treatment with such intravascular devices are also provided. In addition, the present invention provides methods for treating sickle cell disease using Syk inhibitors.

Patent Agency Ranking